During this time, Novartis also had many breakthroughs in the pharmaceuticals sector. One of the most significant advanced in cancer treatment in the first decade of the 21st century was Glivec ...

Current treatment for these patients relies on first-generation TKI imatinib – sold by Novartis as Glivec but also available as a generic – as well as second-generation drugs such as Bosulif ...

North Carolina economic development officials have terminated an economic incentives agreement for Novartis Gene Therapies, which hasn’t met hiring targets tied to a package that promised up to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novartis’ expansion will substantially boost its capital spending, which has run around $1 billion the past several years. It will also broaden Novartis’ commercial footprint, adding six new ...

Novartis shares are trading higher after the company announced it will commit $23 billion to expand US manufacturing over the next 5 years.

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Job Title Sort ascending Business Location Site Date Posted Medical Affairs Lead Regolare, Full time Germany +Alternative Locations Munich (Non-Sales Force) (Novartis Pharma GmbH) Apr 11, 2025 ...

We reimagine medicine to improve and extend people’s lives.